This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Tohoku University, Meiji Co., Ltd.. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Miyagi, JP (2012)
- Sendai, JP (2018)
Company Filing History:
Years Active: 2012-2026
Title: Haruki Kitazawa: Innovator in Antiviral Research
Introduction
Haruki Kitazawa is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of antiviral research, particularly in the detection of mammary gland diseases. With a total of 3 patents to his name, Kitazawa's work is recognized for its innovative approaches and practical applications.
Latest Patents
One of Kitazawa's latest patents focuses on an antiviral agent and a detection method for mammary gland disease. The objective of this invention is to provide an early detection method for mastitis that is both easy and quick compared to prior methods. This method utilizes the level of cyclophilin A in a mammary gland or in milk as an indicator for examining mammary gland diseases. The process involves specific steps that enhance the accuracy and efficiency of mastitis detection.
Career Highlights
Throughout his career, Haruki Kitazawa has worked with esteemed institutions such as Tohoku University and Meiji Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research and technology.
Collaborations
Kitazawa has collaborated with notable colleagues, including Hisashi Aso and Tadao Saito. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of research.
Conclusion
Haruki Kitazawa's contributions to antiviral research and his innovative detection methods for mammary gland diseases highlight his importance as an inventor. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

